TY  - JOUR
AU  - Higuera Gómez, Oliver
AU  - Moreno Paul, Amaia
AU  - Ortega Granados, Ana Laura
AU  - Ros Martínez, Silverio
AU  - Pérez Parente, Diego
AU  - Ruiz Gracia, Pedro
AU  - Sáenz Cuervo-Arango, Lucía
AU  - Vilà, Laia
PY  - 2021
DO  - 10.2147/CMAR.S302928
SN  - 1179-1322
UR  - http://hdl.handle.net/10668/18036
T2  - Cancer management and research
AB  - Identifying patient characteristics that define a worse disease prognosis or "high tumor burden" (HTB) status is essential for clinical decision-making and treatment selection in metastatic non-small cell lung cancer (mNSCLC). We aimed to define this...
LA  - en
KW  - lactate dehydrogenase
KW  - metastatic locations
KW  - non-small cell lung cancer
KW  - number of metastases
KW  - tumor size
KW  - “high tumor burden”
TI  - "High Tumor Burden" in Metastatic Non-Small Cell Lung Cancer: Defining the Concept.
TY  - research article
VL  - 13
ER  -